Clincosm LogoSign in Get a demo

Tolerability

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

Safety Issues, Tolerability, Pharmacokinetics Trial (SB17170, Placebo)

Not yet recruiting
  • Safety Issues
  • +3 more
  • (no location specified)
Apr 2, 2023

Drug Resistant Epilepsy, Ketogenic Diet, Feasibility Trial in Ho Chi Minh city (Ketogenic diet)

Completed
  • Drug Resistant Epilepsy
  • +5 more
  • Ketogenic diet
  • Ho Chi Minh city, Ho Chi Minh, Vietnam
    N02 Children's Hospital
Jan 15, 2023

Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)

Recruiting
  • Pharmacokinetics
  • +2 more
  • 5-methoxy-N,N-dimethyltryptamine succinate salt
  • Placebo
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc
Jan 13, 2023

Safety Issues, Pharmacokinetics, Drug Interaction Trial in Uppsala (Linaprazan glurate, Drug drug interaction (DDI) -

Recruiting
  • Safety Issues
  • +3 more
  • Linaprazan glurate
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trials Consultants AB
Dec 19, 2022

Combination of Ertugliflozin And Sitagliptin Efficacy, Safety &

Not yet recruiting
  • Efficacy
  • +2 more
  • Combinations of Oral Blood Glucose Lowering Drugs
  • (no location specified)
Oct 3, 2022

Safety, Tolerability, Pharmacokinetics Trial in Glendale (AZD7503, Placebo)

Recruiting
  • Safety
  • +3 more
  • Glendale, California
    Research Site
Aug 16, 2022

Pharmacokinetics, Tolerability, Safety Trial in Warngau (AP707)

Completed
  • Pharmacokinetics
  • +2 more
  • Warngau, Bavaria, Germany
    Phase I Unit of CannaXan GmbH
Jul 25, 2022

Safety, Tolerability Trial in Leeds (AM1476 - Placebo)

Completed
  • Safety
  • Tolerability
  • AM1476 - Placebo
  • Leeds, United Kingdom
    Covance Clinical Research Unit
Feb 15, 2022

Healthy Volunteers, Tolerability, Safety Trial in Uppsala (Probiotic, Placebo)

Completed
  • Healthy Volunteers
  • +2 more
  • Probiotic
  • Placebo
  • Uppsala, Sweden
  • +1 more
Jan 28, 2022

Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)

Completed
  • Safety
  • +3 more
  • Bepotastine Besilate
  • Guadalajara, Jalisco, Mexico
    Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021

Safety Issues, Tolerability, Pharmacokinetics Trial in Austin (IPG7236)

Recruiting
  • Safety Issues
  • +2 more
  • Austin, Texas
    NEXT Oncology
Dec 1, 2021

Pharmacokinetic, Tolerability, Safety Trial in Warngau (AP701)

Completed
  • Pharmacokinetic
  • +2 more
  • Warngau, Bavaria, Germany
    Phase I Unit of CannaXan GmbH
Mar 9, 2021

Safety, Tolerability, Feasibility Trial in Germany (MDG1011, Investigator Choice therapy)

Recruiting
  • Safety
  • +3 more
  • Dresden, Germany
  • +8 more
Jan 8, 2020

Safety, Tolerability, Pharmacokinetics Trial in London (DS-1971, )

Completed
  • Safety
  • +2 more
  • London, United Kingdom
    Hammersmith Medicines Research Ltd.
Dec 20, 2018

Safety, Tolerability, Pharmacokinetics Trial in Berlin (AZD9567 Monohydrat, Placebo oral suspension/ Placebo capsule,

Completed
Has Results
  • Safety
  • +5 more
  • AZD9567 Monohydrat
  • +2 more
  • Berlin, Germany
    Research Site
Sep 27, 2018

Safety, Tolerability, Pharmacodynamics Trial in Leiden (ACT-462206 5 mg, ACT-462206 25 mg, ACT-462206 100mg)

Completed
  • Safety
  • +3 more
  • ACT-462206 5 mg
  • +8 more
  • Leiden, Netherlands
    Centre for Human Drug Research
Jul 6, 2018

Safety, Tolerability, Pharmacokinetics Trial in Harrow (AZD9977, oral suspension, Placebo, oral suspension, AZD9977, oral

Completed
Has Results
  • Safety
  • +3 more
  • AZD9977, oral suspension
  • +2 more
  • Harrow, United Kingdom
    Research Site
Mar 28, 2017

Effects of Heat, Tolerability, Adhesiveness Trial in Pinellas Park (Thermal Adhesion Patch, Marketed Thermal Adhesion Patch,

Completed
  • Effects of Heat
  • +3 more
  • Thermal Adhesion Patch
  • +2 more
  • Pinellas Park, Florida
    Radiant Research, Inc.
Mar 15, 2017

Effects of Heat, Tolerability, Adhesiveness Trial in Pinellas Park (Thermal Adhesive Patch, Marketed Thermal Adhesive Patch,

Completed
  • Effects of Heat
  • +3 more
  • Thermal Adhesive Patch
  • +2 more
  • Pinellas Park, Florida
    Radiant Research, Inc
Mar 15, 2017

Comfort, Tolerability Trial in Gainesville (Study Procedures)

Completed
Has Results
  • Comfort
  • Tolerability
  • Study Procedures
  • Gainesville, Florida
    Malcom Randall VA Medical Center
Oct 3, 2016

Safety, Tolerability, Pharmacokinetics Trial in Neptune (MLN3126, MLN3126 Matched Placebo)

Terminated
Has Results
  • Safety
  • +3 more
  • Neptune, New Jersey
    (unnamed)
Jul 18, 2016

Safety, Tolerability, Pharmacokinetics Trial in Nottingham (Dexanabinol Dose Level 1, Dexanabinol Dose Level 2, Dexanabinol Dose

Completed
Has Results
  • Safety
  • +3 more
  • Dexanabinol Dose Level 1
  • +5 more
  • Nottingham, Nottinghamshire, United Kingdom
    Quotient Clinical
May 17, 2016

Tolerability Trial in Overland Park (AZD5213, Placebo)

Completed
  • Tolerability
  • Overland Park, Kansas
    Research Site
Jan 27, 2015

Pharmacokinetics, Tolerability Trial in Miami (Androxal, Placebo)

Completed
Has Results
  • Pharmacokinetics
  • Tolerability
  • Miami, Florida
    Clinical Pharmacology of Miami
Jul 23, 2014